{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:08:09Z","timestamp":1790662089060,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6311,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1111\/j.1538-7836.2005.01470.x","type":"journal-article","created":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T08:46:57Z","timestamp":1123750017000},"page":"2117-2119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Homocysteine and tissue factor pathway inhibitor levels in patients with Fabry's disease"],"prefix":"10.1016","volume":"3","author":[{"given":"S.","family":"FEDI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"GENSINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"GORI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"ABBATE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"BORSINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0010","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3733","article-title":"Alpha\u2010galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0140-6736(00)03554-6","article-title":"Anderson\u2010Fabry's disease: \u03b1\u2010galactosidase deficiency","volume":"357","author":"Peters","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0020","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic disease and stroke: a meta\u2010analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s100720200025","article-title":"Anderson\u2010Fabry disease with cerebrovascular complications in two Italian families","volume":"23","author":"Borsini","year":"2002","journal-title":"Neurol Sci"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activate protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0035","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2019\u2010untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0037-1615053","article-title":"The high prevalence of thermolabile \u00a05\u201310 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease\u00a0(CAD)","volume":"79","author":"Abbate","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0045","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/01.STR.32.7.1559","article-title":"Enhanced endothelium\u2010dependent vasodilatation in Fabry disease","volume":"32","author":"Altarescu","year":"2001","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","article-title":"Profile of endothelial and leukocyte activation in Fabry patients","volume":"47","author":"DeGraba","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0055","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperfusion and nitric oxide pathway dysregulation in Fabry disease. Reversal by enzyme replacement therapy","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0021-9150(97)00090-7","article-title":"Stimulation of endothelial nitric oxide production by homocyst(e)ine","volume":"132","author":"Upchurch","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1651-2227.2002.tb03112.x","article-title":"Endothelial markers and homocysteine in patients with classic Fabry disease","volume":"91","author":"Demuth","year":"2002","journal-title":"Acta Paediatr Suppl"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.nutr.19.1.217","article-title":"Homocysteine metabolism","volume":"19","author":"Selhub","year":"1999","journal-title":"Ann Rev Nutr"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0075","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2165\/00003495-200262040-00005","article-title":"Drugs affecting homocysteine metabolim","volume":"62","author":"Desouza","year":"2002","journal-title":"Drugs"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0080","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1096-7192(03)00136-7","article-title":"Fabry disease: D313Y is an alpha\u2010galactosidase A sequence variant that causes pseudodeficient activity in plasma","volume":"80","author":"Froissart","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0085","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0037-1616518","article-title":"Structure and biology of tissue factor pathway inhibitor","volume":"86","author":"Bajaj","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01470.x_bb0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0021-9150(99)00444-X","article-title":"Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls","volume":"152","author":"Blann","year":"2000","journal-title":"Atherosclerosis"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2005.01470.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622161611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622161611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2005.01470.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:34:46Z","timestamp":1761532486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622161611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1538783622161611"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01470.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine and tissue factor pathway inhibitor levels in patients with Fabry's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01470.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}